Dr Nicola Burgess-Brown
Principal Investigator, SGC, University of Oxford

Nicola Burgess-Brown obtained a First Class degree in Applied Biochemical Sciences from the University of Ulster in 1997 and spent the following year working as a molecular biologist for SmithKline Beecham. She received her Ph.D. in Molecular Microbiology “Quorum Sensing and Regulation of Virulence Gene Expression in Porphyromonas gingivalis” at the University of Nottingham in 2001. Nicola returned to industry to work on high-throughput cloning and validation of therapeutic cancer antigens for Oxford Glycosciences and subsequently Celltech R&D Ltd. Since joining the SGC in 2004, Nicola has been responsible for optimising the high-throughput screening processes from cloning to expression and purification of human proteins for structural and functional studies. In June 2009, Nicola developed a similar pipeline for production of human integral membrane proteins (IMPs) using the baculovirus/ insect cell expression system. Since June 2011, Nicola has been the Principal Investigator of Biotechnology, responsible for all biotech research (working with soluble proteins, membrane proteins and epigenetics targets) for the Oxford site.